Blog

  • CPET Test Interpretation, Part 4: Interpretation and Summary

    After
    having gone through the descriptive checklists for ventilatory, gas
    exchange and circulatory limitations the reason(s) for a patient’s
    exercise limitation, if any, should be reasonably clear. However,
    one of the first questions that should be asked when reading an
    exercise test is what was the purpose of the test?

    • Maximum
      safe exercise capacity for
      Pulmonary Rehab?
    • Rule
      in/rule out exercise-induced bronchospasm?

    • Pre-operative
      assessment?

    • Dyspnea
      of uncertain etiology?

    • What
      is the primary limitation to exercise (pulmonary or cardiac)?

    • Is
      deconditioning suspected?

    The
    interpretation and summary should address these concerns.

    The
    descriptions checklist
    is
    the main
    groundwork for the actual
    interpretation and any
    abnormal findings there may
    signal the need for specific comments.
    The interpretation should start by indicating whether or not the
    patient’s exercise capacity was normal and then should indicate the
    presence or
    absence of any limitations.

    What
    was the patient’s maximum exercise capacity (maximum VO2)?

    • >120%
      = Elevated

    • 80%
      to 120% = Normal

    • 60%
      to 79% = Mildly reduced

    • 40%
      to 59% = Moderately reduced

    • <40%
      = Severely reduced

    Example:
    There was a {elevated | normal | mildly reduced | moderately reduced
    | severely reduced} exercise capacity as indicated by the maximum
    oxygen consumption of XX%.

    Why
    was the test terminated?

    Does
    the reason the test was terminated have any clinical significance?

    Example:
    Testing was terminated due to xxxxxxx.

    Was
    the test adequate or submaximal?

    Testing
    was adequate if:

    • The
      maximum VO2 was ≧80%
      of predicted
    • The
      maximum Minute Ventilation was ≧85%
      of predicted
    • SaO2
      decreased >3%
      during exercise
    • RER
      was greater than 1.10 (bicycle ergometer) or 1.05 (treadmill)

    • The
      maximum Heart rate was ≧85%
      of predicted
    • There
      was a VO2 plateau

    • FEV1
      decreased by ≧15%
      following exercise-induced
    • Testing
      was terminated due to safety concerns (ECG abnormalities, systolic
      or diastolic hypertension, chest
      pain, patient dizziness or
      fainting)

    If
    the test was not adequate then it was submaximal.

    Example:
    {There was an adequate exercise test effort as indicated by xxxxxx. |
    Test was submaximal.}

    Was
    there a ventilatory limitation to exercise?

    The
    gold standard for a ventilatory limitation is whether the maximum
    minute ventilation was ≧85%
    of predicted. In patients with COPD a ventilatory limit can
    also be shown when the Vt/IC
    ratio is ≧85%
    and there has been an increase in EELV of ≧0.25
    L.

    Example:
    {There was no ventilatory
    limitation to exercise. |
    There was a ventilatory
    limit to exercise as indicated by {the maximum minute ventilation of
    XX% of predicted | the Vt/IC of X.XX and increase in EELV of X.XX
    L.}}

    Was
    there an abnormal ventilatory response to exercise?

    An
    abnormal ventilatory response to exercise can include a respiratory
    rate >55, an blunted
    increase in tidal volume of
    less than 2 times baseline, a Vt/IC ratio ≧85%
    or an increase in EELV of ≧0.25
    L. In an adequate test and
    in the absence of an true
    ventilatory limitation these factors will likely contribute to the
    patient’s sensation of dyspnea.

    Example:
    {The elevated respiratory rate | blunted increase in tidal volume |
    elevated Vt/IC ratio | elevated increase in EELV} likely contributes
    to the patient’s sensation of dyspnea.

    Was
    there post-exercise bronchoconstriction or bronchodilation?

    A
    significant change in post-exercise FEV1 is a decrease or increase of
    ≧15%.

    Example:
    {There was a significant
    decrease in FEV1 following exercise which suggests Exercise-Induced
    Bronchoconstriction. | There was no significant changed in FEV1
    following exercise. | There was a significant increase in FEV1
    following exercise which although normal suggests the presence of
    labile airways.}

    Was
    there evidence of a gas exchange limitation?

    The
    gold standard for a gas exchange limitation is whether the SaO2
    decreased by ≧3%.
    Pulmonary vascular disease is likely when this is accompanied by a
    low DLCO and/or
    an elevated Ve/VCO2.

    Example:
    {There was no significant gas exchange limitation. |
    There was a gas exchange
    limitation to exercise as indicated by the decrease in SaO2 of X%.}
    {{The reduced DLCO of XX% of predicted | The elevated Ve/VCO2 of XX}
    suggests pulmonary vascular disease.}

    Was
    there evidence of inefficient ventilation?

    Inefficient
    ventilation is indicated by an elevated Ve/VCO2 or Ve-VCO2 slope, or
    by a reduced maximum PetCO2. In an
    adequate test and in the
    absence of a true gas
    exchange limitation these factors likely contribute to the patient’s
    sensation of dyspnea.

    Example:
    The {elevated Ve/VCO2 | reduced maximum PetCO2}indicates an
    inefficient ventilatory response to exercise which likely contributes
    to the patient’s sensation of dyspnea.

    Was
    there evidence of a circulatory limitation to exercise?

    The
    gold standard for a circulatory limitation is a reduced VO2 at
    Anaerobic threshold. In an
    adequate test a reduced
    maximum O2 pulse of <80%
    of predicted suggests a low
    stroke volume while a reduced chronotropic index of
    less than 0.80 suggests
    chronotropic incompetence.

    Example:
    {There was no significant
    evidence of a circulatory limitation to exercise. | There
    was a circulatory limitation to exercise as indicated by the VO2 at
    Anaerobic Threshold of XX%.}
    {The reduced maximum O2 pulse suggests a stroke volume limitation. |
    The reduced Chronotropic Index suggests chronotropic incompetence
    {possibly secondary to the patient’s beta blocker medication
    xxxxxx.}}

    Was
    there evidence of an abnormal circulatory response to exercise?

    A
    reduced maximum O2 pulse (<80%
    of predicted) and a reduced
    (<0.80) or
    elevated
    Chronotropic Index (>1.30)
    in an
    adequate test and in the absence of true circulatory limitation to
    exercise will likely contribute to the patient’s sensation of
    dyspnea.

    Example:
    The {reduced
    maximum O2pulse | {reduced
    | elevated} Chronotropic
    Index} indicates an abnormal
    circulatory response to exercise which likely contributes to the
    patient’s sensation of dyspnea.

    Was
    there evidence of hypertension or hypotension?

    If
    the systolic blood pressure was >160 mm Hg or the diastolic blood
    pressure was >100 mm Hg at rest or during exercise then there was
    a hypertensive response to exercise. If the systolic pressure did
    increase at least 10 mm Hg or decreased during exercise then there
    was a hypotensive response to exercise.

    Example:
    {There was a normal blood pressure response to exercise. | There was
    a {systolic | diastolic} hypertensive response to exercise as
    indicated by the blood pressure of XXX/XXX. | There was a hypotensive
    response to exercise as indicated by {the increase in systolic
    pressure of <10 mm Hg | the decrease in systolic pressure to XXX.}

    Was
    there clinical or ECG evidence of cardiac ischemia?

    Any
    significant ECG changes or patient complaint of chest pain should be
    documented.

    Example:
    {There were significant ECG
    changes in the {presence | absence} of chest pain. | There was chest
    pain in the absence of significant ECG changes.}

    Summary:

    The
    summary should include only the primary findings from the
    interpretation. Determining the primary cause of any exercise
    limitation is easiest when there is only one significant limitation.
    When there are multiple significant limitations then a judgment call
    needs to made about which limitation seems to be primary and which
    seem to be secondary.

    Example:
    Testing showed a {elevated |
    normal | mildly reduced | moderately reduced | severely reduced}
    exercise capacity in an
    {adequate | submaximal}
    exercise test. The primary exercise limitation was {ventilatory |
    gas exchange | circulatory}. {There
    was a secondary {ventilatory | gas exchange | circulatory }limitation
    to exercise.} {An {abnormal ventilatory | inefficient gas exchange |
    abnormal circulatory} response to exercise likely contributes to the
    patient’s sensation of dyspnea.}

    Interpreting
    a CPET requires a good understanding of cardiopulmonary physiology
    but it
    really isn’t that much more difficult than interpreting regular
    PFTs. Although
    at first glance the multitude of parameters may
    look
    confusing each
    parameter has something distinct to say about any limitations to the
    flow of oxygen and carbon dioxide during exercise and once they are
    organized
    the
    results
    become much clearer. Hopefully
    the approach I’ve detailed here will help make the interpretive
    process more
    straightforward.

    Previous: CPET Test Interpretation, Part 3: Circulation

    Cheat sheet:

    CPET Interpretation Cheat Sheet

    Previous
    discussions of CPET issues:

    How
    does a CPET show a Cardiac limitation?

    Exercise
    and the IC, EELV and Vt/IC ratio

    When
    hypoventilation is the primary CPET limitation

    What
    does an inverse I:E ratio during exercise mean?

    The
    effects of anemia on exercise

    Diagnosing
    Mitochondrial Myopathies

    The
    CPET’s not over until it’s over

    There’s
    more than one way to determine AT

    What’s
    a normal post-pneumonectomy CPET?

    What
    does it mean when Ve exceeds its predicted during a CPET?

    Is
    it dynamic hyperinflation or something else?

    When
    a Pulmonary Mechanical Limitation to exercise isn’t the real
    limitation

    Ve-VCO2
    slope: Just to AT or all the way to the peak?

    Exercise
    oscillatory ventilation

    DLO2/QC,
    SaO2 and CPETs

    PETCO2
    during exercise, a quick diagnostic indicator

    Chronotropic
    Index and O2 pulse

    Peak
    VO2 and low body weight

    Recommended
    reading:

    ATS/ACCP
    Statement on cardiopulmonary exercise testing. Am J Resp Crit Care
    2003; 167: 211-277.

    Balady
    GJ; et al. Clinician’s guide to cardiopulmonary exercise testing in
    adults: A scientific statement from the American Heart Association.
    Circulation 2010; 122: 191-225.

    Palange
    P, et al. ERS Task Force: Recommendations on the use of exercise
    testing in clinical practice. Eur Respir J 2007; 29: 185-209.

    Wasserman
    K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of exercise
    testing and interpretation. Lippincott, Williams and Wilkins,
    publisher.


    PFT
    Blog by Richard
    Johnston

    is
    licensed under a Creative
    Commons Attribution-NonCommercial 4.0 International License
    .

  • 2019 ATS/ERS Spirometry Standards

    The
    2019 ATS/ERS Spirometry Standards were recently released. The
    standards are open-access
    and can be downloaded
    without charge from the October
    15
    th
    issue of the American Journal of Respiratory and Critical Care
    Medicine.
    Supplements
    are available from the same web
    page.

    The
    2019 Spirometry Standards have been extensively re-organized with
    numerous updates. Notably, a number of sections that were previously
    discussed in the 2005 General Considerations for Lung Function
    Testing have been updated and included in the 2019 Spirometry
    Standards. Also notably, a number of stand-alone spirometry tests,
    including the Flow-Volume Loop, PEF and MVV are not included in the
    2019 Standards.

    An
    overview of changes and updates from the 2005 Spirometry Standards
    are detailed within the 2019 Spirometry Standards (page e71, column
    1, paragraph 2) and in the Data Supplement (pages E2-E3). In more
    detail these include:

    ◆ The
    list of indications for spirometry (page e73, table 1) was updated
    primarily with changes in language.

    • “To
      measure the effect of disease on pulmonary function” was updated
      to “To measure the physiological effect of disease or disorder”

    • “To
      describe the course of diseases that affect lung function” was
      updated to “To monitor disease progression”
    • “To
      monitor people exposed to injurious agents” was updated to “To
      monitor people for adverse effects of exposure to injurious agents”

    ◆ Items
    added to indications:

    • “Research
      and clinical trials”
    • “Preemployment
      and lung health monitoring for at-risk occupations”


    Contraindications were
    previously mentioned in the 2005 General Considerations rather than
    the 2005 Spirometry Standards and these have been extensively updated
    and expanded. Although the list of contraindications (page e74,
    table 2) is fairly inclusive (and should be reviewed by all
    concerned) there were items mentioned in the body of text that were
    not in the table:

    • “Spirometry
      should be discontinued if the patient experiences pain during the
      maneuver.”
    • “…because
      spirometry requires the active participation of the patient,
      inability to understand directions or unwillingness to follow the
      directions of the operator will usually lead to submaximal test
      results.”

    ◆ Notably,
    abdominal aortic aneurysm (AAA) was not included as a
    contraindication in the 2019 standards. (page e72, column 3,
    paragraph 1)

    ◆ “Ambient
    temperature, barometric pressure, and time of day must be recorded.”
    (page e72, column 3, paragraph 2) This was mandated in the 2005
    General Considerations and is now included in the 2019 Spirometry
    Standards.

    ◆ Patient
    testing considerations (page
    e72, column 3, paragraph 3) have
    been expanded and now includes:

    • “Testing
      should preferably occur in a quiet and comfortable environment that
      is separated
      from the waiting room and other patients being tested.”
    • “Drinking
      water should be available. Tissues or paper towels should be offered
      to help patients deal with secretions.”
    • “A
      smaller chair or a raised footstool should be provided for children
      and small adults.”

    ◆ The
    effects of testing in different positions is discussed
    (page e73, column 1,
    paragraph 1) and “If
    testing is undertaken with the patient in another position, this must
    be documented in the report.”

    ◆ Although mentioned in the 2005 General Considerations (pages 155-157) an abbreviated version of hygiene and infection control has been included in the 2019 Spirometry Standards (page e73, column 1, paragraph 1 and page e78, table 6).

    ◆ Spirometer
    specifications must meet ISO 26782 standards. (page
    e73, column 3, paragraph 3)
    There are however, no significant differences in spirometer accuracy

    3%) from the 2005 Spirometry Standards. However
    the 2005 Spirometry Standards noted that “if the [calibration]
    syringe has an
    accuracy of 0.5%, a reading of ±3.5%
    is appropriate whereas in the 2019 Spirometry standards it is assumed
    that it is a “±3%
    accuracy tolerance, ±2.5%
    for spirometers plus ±0.5%
    for calibration syringes”.

    ◆ The
    specifications for digitization of analog flow or volume signals are
    higher than the 2005
    Standards (“…sampling
    rate must be ≥100
    Hz with a minimum resolution of 12 bits.”, (page
    e74, column 1, paragraph
    1)).
    This
    sampling rate was indirectly specified in the proposed reporting
    format in the 2005 Spirometry Standards (page 335, column
    1, paragraph 2) but was
    not specifically part of the spirometry equipment requirements.

    ◆ Manufacturers
    are now required to provide an alert if a calibration is ±
    2SD from the mean calibration factor or ±
    6% from the previous calibration factor (page e75, column
    1, paragraph 2).

    ◆ A
    summary of mandated alert signals is included in the Data Supplement
    (pages E30-E31).

    ◆ Quality
    assurance now includes the statement “Precalibrated spirometers
    cannot be recalibrated by the operator but must still undergo a
    calibration verification. Manufacturers must specify the action to be
    taken if a precalibrated device fails the calibration verification.”
    (page e75, column 1, paragraph 1)

    ◆ Quality
    assurance now includes the statement “Spirometry software must
    include the ability to generate a report of calibrations that
    includes the results of all verifications, the number of failed
    calibration verifications in each session, and the changes in
    calibration factors.” (page e75, column 1, paragraph 1)

    ◆ The 2019 Standard mandates that “The spirometry system must determine the
    zero-flow level with the spirometer blocked before calibration,
    calibration verifications, and patient tests.” (page e75, column
    1, paragraph 3). Zero-flow levels were not discussed in the 2005
    Standards.

    ◆ Quality
    assurance now includes “Verification of reference value
    calculations after software updates”. (page
    e74,
    table 3)

    ◆ Biological
    QC is mentioned (page e75, column 2,paragraph 3) but it
    is also indicated that “A biological control is not a substitute
    for the use of a calibration syringe.” and that “In some
    jurisdictions, including a biological control in quality control
    reporting may constitute a breach of employee privacy protection.”

    ◆ Age
    must now be reported in years to one decimal point. Height must now
    be reported in centimeters to one decimal point. Weight must now be
    reported in kilograms to the closest 0.5 kg. (page e75, column 3,
    paragraph 2)

    ◆ Estimating
    height from arm span or ulna length with reference equations is
    discussed in the Data Supplement. (pages E27-E28).

    ◆ Patient
    details now includes the statement “In persons aged 25 years or
    older, for whom a reliable height measurement has been made
    previously in the same facility, remeasuring height at subsequent
    visits within 1 year may not be necessary.” (page e75, column 3,
    paragraph 2)

    ◆ Patient details now includes a statement acknowledging transsexual / transgender patients: “When requesting birth sex data, patients should be given the opportunity to provide their gender identity as well and should be informed that although their gender identity is respected, it is birth sex and not gender that is the determinant of predicted lung size. Inaccurate entry of birth sex may lead to incorrect diagnosis and treatment.” (page e75, column 3, paragraph 3)

    ◆ In
    the 2005 Standards the only smoking was indicated as an activity that
    should be avoided prior to testing (page 327, column 3, paragraph 3).
    The 2019 Standards indicates a number of additional activities that
    should be avoided prior to testing (page e77, table 5).

    ◆ Like the 2005 Spirometry Standards, the 2019 Spirometry Standards notes “Well-fitting dentures are usually left in place.” but also notes that “…a larger 2018 study found that FVC was an average of 0.080 L higher when dentures were removed”
    (page e76, column 2, paragraph 2)

    ◆ The
    FVC maneuver now includes a fourth phase “inspiration at maximal
    flow back to maximum lung volume” not present in the 2005
    Standards. (page e76, column 3, paragraph 3)

    ◆ Expiratory
    time is now either until EOT (End
    of Test)
    criteria has been met or when the expiratory reaches 15 seconds. The
    2005 Spirometry Standard of “…and
    the subject has tried to exhale for ≥3 s in children aged >10
    yrs and for ≥6 s in subjects aged >10 yrs” no longer applies.
    (page e77, column 1, paragraph 2)

    ◆ The
    2019 Standard now mandates that “The
    spirometry system must signal the operator when a plateau has been
    reached or forced expiratory time (FET) reaches 15 seconds.” (page
    e77, column 1, paragraph 2)

    ◆ The 2019 Spirometry Standard now indicates that “With appropriate coaching, children as young as 2.5 years old with normal cognitive and neuromotor function are able to perform acceptable spirometry” (page e77, column 2, paragraph 3) whereas the 2005 Standard stated “children as young as 5 yrs of age are often able to perform acceptable spirometry”.

    ◆ The back-extrapolation method has been updated to “At the point of PEF on the volume–time graph, a tangent is drawn with a slope equal to PEF, and its intersection on the abscissa defines Time 0, which becomes the start for all timed measurements.”
    (page e77, column 3, paragraph 4)

    ◆ Extrapolated
    Volume (EV) has been updated to Back Extrapolated Volume (BEV).
    (page e77, column 3,
    paragraph 4)

    ◆ The
    minimum acceptable
    level of back extrapolation has been updated to “<5%
    of the FVC or 0.100 L, whichever is greater” from “<5%
    of the FVC or 0.150 L, whichever is greater” (page
    e77, column 3,
    paragraph 4)

    ◆ Hesitation
    time, which is not mentioned in the 2005 Standards and
    is “…defined as the time from the point of maximal inspiration to
    Time 0, should be 2 seconds or less” (page
    e77, column 3, paragraph 4)

    ◆ End
    of Test (EOT) acronym has
    been replaced with End of Forced Exhalation (EOFE).
    (page e78, column 2,
    paragraph 1)

    ◆ EOFE
    is considered acceptable when an expiratory time of 15 seconds has
    been reached. Test equipment must acknowledge this expiratory time
    with a double beep. (page e78, column 3, paragraph 2)

    ◆ EOFE is considered acceptable when “The patient cannot expire long enough to achieve a plateau (e.g., children with high elastic recoil or patients with restrictive lung disease). In this case, the measure of whether EOFE has been reached
    is for the patient to repeatedly achieve the same FVC.” (page e78,
    column 3, paragraph 3)

    ◆ The
    2019 Spirometry standards include a discussion of the criteria
    differences between acceptability and usability of spirometry
    efforts. (page e79, table 7)

    ◆ The 2019 Spirometry Standards notes “Maneuvers that do not meet any of the EOFE acceptability criteria will not provide acceptable FVC measures. However, an acceptable FEV1 measurement may be obtained from a maneuver with early termination
    after 1 second.” (page e79, column 1, paragraph 2)

    ◆ The 2019 Spirometry Standards includes the FIVC in the assessment of the FVC. Specifically “If the volume of the maximal inspiration (i.e., FIVC) after EOFE is greater than FVC, then the patient did not start the maneuver from TLC. FEV1 and FVC measurements from a maneuver with FIVC-FVC > 0.100 L or 5% of FVC, whichever
    is greater, are not acceptable.” (page e79, column 3, paragraph 2)

    ◆ The
    2019 Standards indicates that “The spirometry system software must
    provide explicit feedback to the operator indicating FEV1 and FVC
    acceptability at the completion of each maneuver.” (page
    e80, column 2, paragraph 2) This
    was suggested in the 2005 Standards but was not mandatory.

    ◆ The
    2005 Standards included repeatability criteria
    based on FVC volume (“For
    those with an FVC of 1.0 L, both these values [the
    difference between the largest and next largest FVC and FEV1]
    are
    0.100 L (page 325, column
    1, paragraph 7)). The
    2019 standard uses this repeatability
    criteria for ages ≤ 6 years, but not for any value of FVC. (page
    e80, column 3, paragraph 2)

    ◆ Both
    the 2005 and 2019 Spirometry Standards indicate that the maximum
    number of FVC maneuvers in adults should be eight. The 2019
    Standards, however, suggests that “When testing children, more than
    eight attempts may be required because each attempt may not be a full
    maneuver.” (page e81, column 1, paragraph 1)

    ◆ The
    list of medications that should be withheld prior to reversibility
    testing has been updated with significantly different withholding
    times. (page e82, table 8).

    ◆ Recommended
    reversibility testing protocols are detailed in the Data Supplement
    (pages E32-E35).

    ◆ The
    2005 Spirometry Standard discussed a variety of values that could be
    reported whereas the 2019 Standard mandates those that must be
    reported (page e82, table 9)

    ◆ The
    2019 Spirometry Standard requires that FIVC be reported. (page e82,
    table 9).

    ◆ The
    selection and limitations of FEF25-75
    is discussed in the 2019 Standards. (page e82, column 2, paragraph
    2)

    ◆ The 2019 Standards recommends that the 2017 ATS reporting standards and the GLI reference equations be used for reporting spirometry results. (page e82, column 3, paragraph 2)

    ◆ The 2005 Spirometry Standards included a section on performing a flow-volume loop as a maneuver separate from spirometry (pages 326-328). The 2019 Standards mandates that the flow-volume loop is an integral part of spirometry. (page e82, column 3, paragraph 2)

    ◆ The
    2005 Standards includes
    a section on normal and abnormal flow-volume loops with 7 examples
    (pages 327-328). This was not present
    in the 2019 Standards. Flow-volume
    loop examples are included in the Data Supplement (pages E4-E20).

    ◆ The
    2019 Spirometry standards suggests but does not mandate that reports
    should be exported as a .PDF file and that data should be exported
    using the Clinical Document Architecture Release 2 standard of HL7
    International or Fast Healthcare Interoperability Resources. (page
    e82, column 3, paragraph 2)

    ◆ Database
    elements are mandated and detailed in the Data Supplement (pages
    E35-E38). The ability to export data in .XML format is mandated.

    ◆ The
    date and time for each maneuver must be recorded ((page e82, column
    3, paragraph 3)

    ◆ The
    2019 Standard suggests that all reported spirometry efforts be graded
    by repeatability.
    (page e83, table 10) (page
    e83, column 1, paragraph 2)

    ◆ The stability of tidal breathing prior to a slow VC maneuver is defined and its effect on IC is discussed in the 2019 Standards (“Stability is defined as having at least three tidal breaths with end-expiratory lung volume within 15% of the VT”). (page e84, column 1, paragraph 2). This was not previously discussed in the 2005 Standards.

    ◆ The
    2019 Standards mandates that during a slow VC maneuver “The test
    system must provide both a visual and an audible signal (single beep)
    when a stable end-expiratory tidal lung volume is detected or there
    have been 10 tidal breaths…” (page e83, column 1, paragraph 3)

    ◆ The 2019 Standards also mandates that during a slow VC maneuver the test system must provide “…for expiration to RV in either IVC or EVC maneuvers, a double beep when a plateau is reached (≤0.025 L in the last second) or the expiration
    time reaches 15 seconds.” (page e83, column 2, paragraph 1)

    ◆ The
    2005 Standards included the procedure for PEF testing (pages
    330-331). This was not discussed in the 2019 Standards.

    ◆ The
    2005 Standards included the procedure for MVV testing (page 331).
    This was not discussed in the 2019 Standards.

    *
    * *

    This
    is a welcome update to the previous 2005 ATS/ERS Spirometry
    Standards. Many deficiencies in the prior Standards have been
    corrected and the new
    standards are more pertinent to the current level of technology. As
    usual, it will probably take a while before the existing software is
    updated to reflect the new standards and in some cases this may never
    occur.

    I
    was particularly pleased to see a discussion concerning
    the acceptability and usability of spirometry efforts.
    A spirometry effort does not have to be acceptable to be able to
    provide clinically useful information.

    Although
    the selection criteria for reported results (largest FVC and largest
    FEV1 from any acceptable
    effort) has not changed
    from the 2005 Standards (which is okay) there was no discussion on
    how to indicate
    that reported results
    are a composite nor how to
    link graphical results (flow-volume loops and volume-time curves) to
    composite efforts nor how
    to select other values (such as PEF) for a composite result.

    I
    would have liked to see some movement in the Standards towards
    performing FEV1 and VC maneuvers separately. Interestingly
    this was discussed very
    briefly in the 2005
    Standards (page 326, column 2, paragraph 3) but I could find no
    similar discussion in the 2019 standards.

    Although ethnicity was discussed in the Data Supplement (page E29) I would have liked to see a more in-depth discussion. Ethnicity was acknowledged by both the 2005 and 2019 Standards as being critical to the selection and use of reference equations but the guidelines are somewhat vague and many ethnicities are not represented in existing reference equations.

    I
    am slightly disappointed that the technical requirements for
    spirometry systems has not changed from the 2005 Standards. This
    however is probably realistic since
    measuring
    the flow and volume of exhaled air is technically quite difficult and
    we’ve likely reached
    a plateau in our ability to do this.

    Despite
    all this I am pleased
    overall with the 2019 Standards. They are a distinct step forward
    and should be welcomed by all.

    References:

    Brusasco
    V, Crapo R, Viegi G. ATS/ERS task force: standardisation of lung
    function testing: General considerations for lung function testing.
    Eur Respir J 26: 153-161.

    Brusasco
    V, Crapo R, Viegi G. ‘‘ATS/ERS task force: standardisation of
    lung function testing: Standardisation of spirometry. Eur Respir J
    2005; 26: 319-338.
    1

    Culver
    BH, Graham BL, Coates AL, et al. Recommendations for a standardized
    pulmonary function report. Am J Respir Crit Care Med 2017; 196(11):
    1463-1472

    Graham
    BL, et al. Standardization of Spirometry 2019 Update. Am J Respir
    Crit Care Med 2019; 200 (8): e70-e88.

  • CPET Test Interpretation, Part 3: Circulation

    I
    would like to re-emphasize the importance of the descriptive part of
    CPET interpretation. At the very least consider it to be a checklist
    that should always be reviewed even when you think you know what the
    final interpretation is going to be.

    After
    gas exchange, the next step in the flow of gases is circulation. The
    descriptive elements for assessing circulation are:

    What
    was the maximum heart rate?

    The maximum predicted heart rate
    is calculated from 220 – age.

    A maximum heart rate above 85%
    of predicted indicates that there has been an adequate exercise test
    effort.

    Example:
    The maximum heart rate was XX%
    of predicted {which indicates an adequate test effort}.

    What
    was the heart rate reserve?

    The heart rate reserve is
    (predicted heart rate – maximum heart rate). A heart rate reserve
    that is greater than 20% of the (predicted heart rate – resting
    heart rate) is elevated and may be an indication of either
    chronotropic incompetence or an inadequate test effort.

    Note:
    A negative heart rate reserve
    will occur whenever a patient exceeds their predicted heart rate.

    Example:
    The heart rate reserve is XX
    BPM which is {within normal limits | elevated}.

    What
    was the heart rate recovery (HRR)?

    The heart rate recovery is the
    (maximum heart rate – heart rate at 1 minute post-exercise). A HRR
    < 12 indicates the patient has a reduced vagal and parasympathetic
    tone and carries a higher mortality risk.

    Example:
    The heart rate recovery was
    XX BPM which is {within normal limits | reduced}.

    What
    was the chronotropic index?

    The
    chronotropic index relates the change in heart rate to the change in
    oxygen consumption. A chronotropic index > 1.30 indicates a steep
    heart rate response and can suggest an increased dependence on heart
    rate to increase cardiac output secondary to a low stroke volume. A
    chronotropic index < 0.8 can indicate a blunted heart rate
    response (possible chronotropic incompetence) which in turn can
    suggest a variety of cardiac dysfunctions but can also be caused by
    medication (beta blockers). A low chronotropic index can also be
    seen in exceptionally fit individuals (elevated
    max VO2, elevated VO2 at AT),
    and in these cases, is normal. In
    an exceptionally fit individual a normal chronotropic index is likely
    abnormal.

    Note: Chronotropic index is calculated from:

    and
    is discussed in greater detail in the previous
    posting Chronotropic
    Index and O2 Pulse
    .

    Example:
    The Chronotropic Index was X.XX
    which is {reduced | within normal limits | elevated|.

    What
    was the resting and maximum exercise blood pressure?

    A
    normal max systolic pressure during exercise is 160-220 mm Hg. A
    normal increase in diastolic pressure during exercise is 10 mm Hg. A
    diastolic pressure during exercise greater than 90 Hg is likely
    abnormal and greater than 100 mm Hg is definitely abnormal and
    suggests diastolic dysfunction. If systolic blood pressure did not
    increase to greater than 130 mm Hg, or dropped >10 mm Hg during
    exercise, consider left ventricular dysfunction, possible CAD

    Note:
    Guidelines for the
    maximum allowable blood pressure during exercise remain
    unclear. We use a diastolic pressure ≧
    110 mm Hg or a systolic pressure ≧
    250 mm Hg as an indication to stop testing but each institution will
    have to develop their own guidelines.

    Example:
    The resting blood pressure was
    XXX/XX which is {within normal limits | elevated}. Blood pressure
    increased to XXX/XX during exercise which is {within normal limits |
    elevated}.

    What
    was the systolic blood pressure 3 minutes post-exercise?

    Blood
    pressure should be measured at 3 minutes following exercise
    termination. A
    (3
    minute post-exercise systolic blood pressure / peak exercise systolic
    blood pressure)
    ratio greater than 0.95 indicates a
    blunted post-exercise decrease in blood pressure which is an
    indicator for an increased mortality risk.

    Example:
    There was a {normal | blunted }
    decrease in systolic blood pressure following exercise.

    What
    was the VO2 at Anaerobic Threshold?

    A
    low VO2 at AT indicates an abnormal cardiovascular limitation
    (specifically a reduced O2 delivery to the exercising tissues). The
    LLN threshold (in terms of percent of the predicted VO2) rises with
    age:

    Males:

    • Age:
      20 LLN: 42%

    • Age:
      30 LLN: 43%

    • Age:
      40 LLN: 44%

    • Age:
      50 LLN: 45%

    • Age:
      60 LLN: 46%

    • Age:
      70 LLN: 47%

    Females:

    • Age:
      20 LLN: 41%
    • Age:
      30 LLN: 44%
    • Age:
      40 LLN: 47%
    • Age:
      50 LLN: 49%
    • Age:
      60 LLN: 52%
    • Age:
      70 LLN: 54%

    Note:
    The
    Anaerobic Threshold generated automatically by test system software
    should always be verified. Determining Anaerobic Threshold is
    discussed in greater detail in the previous
    posting There’s
    more than one way to determine AT.

    Example:
    The VO2 at Anaerobic Threshold
    was XX% of predicted which
    is {within normal limits | reduced}.

    What
    was the Heart Rate – VO2 pattern?

    The
    Heart rate and VO2 should be plotted against each other in a graph.
    Normally when this is done there should be a nearly straight line as
    the relationship between heart rate and VO2 tends to be linear. An
    upwards inflection in this line indicates that the heart rate is
    increasing faster than the VO2 and is an indication of a rate-related
    decrease in stroke volume which is often seen in valvular disease.

    Note:
    This is
    discussed in greater detail in the previous
    posting Chronotropic
    Index and O2 Pulse
    .

    Example:
    {There was a normal Heart-Rate
    VO2 pattern} | {There was an abnormal upwards inflection in the Heart
    Rate-VO2 curve occurring at a heart rate of XXX BPM.}

    What
    was the O2 pulse pattern?

    O2
    Pulse is VO2/Heart rate (ml of oxygen consumed per heart beat). A
    normal O2 Pulse response pattern shows an immediate upswing at the
    beginning of exercise and a steady increase thereafter with a peak at
    peak exercise. An early plateau can be abnormal. An O2 Pulse that
    increases and then decreases is definitely abnormal and is usually
    seen in conjunction with an abnormal HR/VO2 curve.

    O2
    Pulse is the product of the a-v O2 Content difference and Stroke
    Volume. If there is no desaturation during exercise then O2 Pulse
    can be an indicator of Stroke Volume.

    O2
    Pulse usually decreases when exercise stops. An increase in O2 Pulse
    after the end of exercise is abnormal
    an usually
    seen in left
    ventricular dysfunction
    and other heart diseases.

    Note:
    This is
    discussed in greater detail in the previous
    posting Chronotropic
    Index and O2 Pulse
    .

    Example:
    {The O2 pulse pattern was
    normal.} | {There was an abnormal decrease in O2 pulse during
    exercise} | {There was an abnormal increase in O2 pulse following
    exercise.}

    What
    was the maximum O2 pulse?

    The maximum predicted O2 pulse is calculated from:

    (Predicted
    Maximum VO2 (ml) / Predicted Maximum Heart Rate)

    A
    maximum O2 pulse < 80% of predicted is likely abnormal and can
    indicate a stroke volume limitation or an inadequate exercise test
    effort.

    Example:
    The maximum O2 pulse was XX.X ml/beat which is {within normal limits
    | reduced}.

    The
    circulatory response to exercise primarily involves the delivery of
    oxygen to the exercising muscles. After having gone through this
    checklist it should be apparent whether the circulatory response to
    exercise was normal or abnormal, and as importantly, specifically
    which element was normal or abnormal.

    A
    significant reduction in cardiac output is primarilysignaled
    by a reduced VO2 at AT and is usually due to either a decrease in
    stroke volume or the inability to increase heart rate (chronotropic
    incompetence). Depending on its severity a reduction in stroke
    volume is usually indicated by a reduced maximum O2 pulse while
    chronotropic incompetence is usually indicated by a reduced
    Chronotropic Index. These findings are not mutually exclusive,
    however and
    some patients will have both indications.

    It
    should also be apparent that it is necessary to review all of the raw
    test data, not just that presented for baseline, AT and peak
    exercise. Summary reports automatically generated by test systems
    often have inaccuracies in how test
    data is selected
    and averaged
    and these reported results should always
    be
    verified.

    Previous: Interpreting CPET Tests, part 2: Gas Exchange

    Next:
    Interpreting CPET Tests, part
    4: Interpretation and Summary

    References:

    Wasserman K, Hansen JE, Sue DY,
    Stringer WW, Whipp BJ. Principles of exercise testing and
    interpretation, 4th edition. Lippincott, Williams and
    Wilkins, publisher.


    PFT
    Blog by Richard
    Johnston

    is
    licensed under a Creative
    Commons Attribution-NonCommercial 4.0 International License
    .

  • CPET Test Interpretation, Part 2: Gas Exchange

    I
    would like to re-iterate the importance of the descriptive part of
    CPET interpretation. At the very least consider it to be a checklist
    that should always be reviewed even when you think you know what the
    final interpretation is going to be.

    After
    ventilation, the next step in the flow of gases is gas exchange. The
    descriptive elements for assessing gas exchange are:

    What
    was the maximum oxygen consumption (VO2)?

    The maximum oxygen consumption
    is the prime indicator of exercise capacity. Predicted values should
    be based on patient height, age, weight and gender.

    Note:
    There is actually a surprising limited number of reference equations
    for maximum VO2. The only one I’ve found that takes weight into
    consideration in a realistic manner is Wasserman’s algorithm. Some
    test systems do not offer this reference equation but I feel it is
    worthwhile for it to
    be calculated and used regardless. See appendix for the algorithm.

    Note:
    The maximum VO2 does not
    necessarily occur at peak exercise (i.e.
    test termination).
    This can happen in various types of cardiac and vascular diseases
    but also because the patient may decrease
    the level of their exercise before
    the test is terminated.

    • Maximum VO2 > 120% of predicted = Elevated
    • Maximum VO2 = 80% to 119% of predicted = Normal
    • Maximum VO2 = 60% to 79% of predicted = Mild impairment
    • Maximum VO2 = 40% to 59% of predicted = Moderate impairment
    • Maximum VO2 < 40% of predicted = Severe impairment

    Example:
    The maximum VO2 was X.XX LPM { which is {mildly | moderately |
    severely } decreased | within normal limits | elevated}.

    What
    was the maximum oxygen consumption in ml/kg/min?

    This value is affected by a
    patient’s BMI and for this reason may have a limited value in
    assessing a patient’s exercise capacity but despite this it has
    been used extensively in disability and pre-operative assessments.
    Underweight patients may have an elevated VO2 in ml/kg/min and
    overweight patients may have a reduced VO2 in ml/kg/min even when VO2
    expressed a LPM is normal.

    • VO2 < 10 ml/kg/min: Surgery is contraindicated.
    • VO2 = 10 to 15 ml/kg/min: Unable to perform most jobs; at increased risk for invasive surgical procedures.
    • VO2 = 15 to 25 ml/kg/min: Able to work at jobs that do not require extended work above 40% of maximum VO2; surgical risk is low.
    • VO2 > 25 ml/kg/min: Able to perform most jobs.

    Example:
    The maximum VO2 was XX
    ml/kg/min.

    Was
    there a VO2 plateau?

    A VO2 plateau is defined as a
    stable, unchanging VO2 for > 1 minute, particularly while the work
    rate is still increasing. When present it suggests the patient has
    achieved their maximum cardiac output. It can also occur in patients
    being exercised at very low work loads.

    Note:
    When looking at raw test data,
    a VO2 plateau should be accompanied by an increase in Minute
    Ventilation (Ve) and CO2 production (VCO2). If these do not continue
    to increase then the VO2 plateau is more likely due to the patient
    slowing down and exercising less than
    it is to a true VO2 plateau.

    Example:
    {There was no VO2 plateau. |
    There was a VO2 plateau occurring during the
    final XX seconds of testing.}

    What
    was the Oxygen Saturation (SaO2) at rest and at maximum exercise?

    A
    resting SaO2 < 95% is abnormal. A decrease in SaO2 during
    exercise ≧
    3% is abnormal.

    Note:
    Oximeter
    readings can be inaccurate at high heart rates, from
    motion
    artifact or poor peripheral circulation.

    Note:
    In
    an adequate test, a
    significant
    decrease
    in SaO2 indicates that the primary exercise limitation is pulmonary
    (either ventilatory
    or vascular) while
    a
    normal
    SaO2 indicates that the primary limitation is cardiac. This
    is discussed in greater detail in the previous posting DLCO/Qc,
    SaO2 and CPETs
    .

    Example:
    The baseline SaO2 was {reduced
    | normal}. There was {no} significant desaturation {to
    XX%} during exercise.

    What
    was the maximum PetCO2?

    End-tidal
    CO2 (PetCO2) is an indirect measurement of ventilatory efficiency and
    is the product of PACO2 and ventilation. Although PetCO2 at rest is
    approximately 2 mm Hg below PaCO2 the relationship between PetCO2 and
    PaCO2 is much less exact during exercise and will be overridden by an
    exaggerated ventilatory response to exercise. PetCO2 should rise
    during exercise and peak near AT, then decrease until maximum
    exercise is attained with a further drop following exercise.

    Note:
    PetCO2 during exercise was
    discussed in greater detail in the previous posting PetCO2
    during exercise, a quick diagnostic indicator.

    An
    arbitrary grading scale for maximum PetCO2 is:

    • ≧ 35 = normal
    • 30 to 35 = mildly reduced
    • 25 to 30 = moderately reduced
    • <25 = severely reduced

    Example:
    The maximum PetCO2 was XX mmHg
    which is {normal | {mildly
    | moderately | severely reduced}}.

    What
    was the RER pattern during exercise?

    The
    Respiratory Exchange Ratio (RER) is VCO2/VO2. A normal resting value
    is 0.70 to 0.90 and is influenced by diet (lower with a high protein
    diet, higher with a high carbohydrate diet). RER usually falls below
    the baseline value at the beginning of exercise (due to a delay in
    VCO2 kinetics) and then increases thereafter.

    An RER of 1.10 or higher at peak
    exercise is an indicator of an adequate exercise test effort.

    Note:
    Patients exercising on a
    treadmill have a greater difficulty in achieving an RER of 1.10 and
    for this reason an RER of 1.05 is likely an
    indication of an adequate test.

    Note:
    When
    elevated at rest (>1.00) this often means nothing more than
    patient anxiety. If the RER
    is elevated at rest and does not decrease below 1.0 during the first
    level of exercise this suggests a metabolic disorder or continued
    hyperventilation.

    Example:
    The RER was X.XX at peak exercise {which indicates an adequate
    exercise test effort}.

    What
    was the Ve/VCO2 at Anaerobic Threshold (AT)?

    Ve/VCO2
    is the amount of
    ventilation
    required per unit of CO2 production. High values suggest inefficient
    ventilation either
    due to ventilatory
    or gas exchange causes.
    Ve/VCO2
    tends to be elevated
    at rest (40-50),
    decreases to minimum value at or shortly after AT, and can then
    increase or remain flat to peak exercise.

    A
    Ve/VCO2 > 35 at AT is likely abnormal and raises the question of
    pulmonary vascular disease or hyperventilation.

    Note:
    A
    diagnosis of pulmonary vascular disease needs a significant decrease
    in SaO2 and/or a reduced DLCO for confirmation.

    Example:
    The Ve/VCO2 at AT was XX which
    is {within
    normal limits | elevated}.

    What
    was the lowest observed Ve/VCO2?

    Anaerobic
    threshold is a somewhat arbitrary point for the assessment of
    Ve/VCO2. This is because the nadir in Ve/VCO2 usually occurs
    following the nadir in Ve/VO2 which is a
    primary marker
    for
    the AT. For the reason the lowest observed Ve/VCO2 may be a more
    accurate reflection of ventilatory efficiency.

    A lowest observed Ve/VCO2 >
    35 is likely abnormal.

    Example:
    The lowest
    observed Ve/VCO2 was XX
    which is {within
    normal limits | elevated}.

    What
    was the Ve-VCO2 slope to AT?

    The
    Ve-VCO2 slope is determined using
    linear regression when Ve is plotted versus VCO2 and like the Ve/VCO2
    is a way to measure the efficiency of gas exchange. The Ve-VCO2
    slope is usually calculated from rest to AT, but peak exercise values
    can be substituted when a patient is unable to reach AT or AT is
    indeterminate. This is discussed in more detail in the previous
    posting Ve-VCO2
    slope: Just to AT or all the way to peak?

    Note:
    My
    personal opinion is that the Ve-VCO2 slope is a more accurate
    reflection of ventilatory efficiency than Ve/VCO2 and this is because
    it is based on a majority of the VCO2 and Ve measurements rather than
    just a few. However, many test systems do not calculate Ve-VCO2
    slope and if needed it must be calculated manually (spreadsheet
    actually, with
    manual
    entry).

    A
    Ve-VCO2 slope to
    AT >
    34 is abnormal and
    carries an increased risk for surgical procedures.

    Example:
    The Ve-VCO2 slope to AT was XX
    which is {within normal limits | elevated}.

    What
    was the Ve-VCO2 slope to peak exercise?

    The AHA recommends calculating
    the Ve-VCO2 slope from rest to peak exercise, rather than just to AT.

    A Ve-VCO2 slope to peak exercise
    < 30 is considered normal. A Ve-VCO2 slope to peak exercise >
    40 is considered abnormal.

    Note:
    The
    Ve/VCO2 slope to peak exercise is highly dependent on how far a
    patient is willing
    to push themselves. An early termination will reduce the peak
    Ve-VCO2 slope. This
    is discussed in more detail in the previous posting Ve-VCO2
    slope: Just to AT or all the way to peak?

    Example:
    The Ve-VCO2 slope to peak
    exercise was XX which is
    {within normal limits | elevated}.

    After having gone through this checklist it should be apparent whether the gas exchange response to exercise was normal or abnormal, and as importantly, specifically which element was normal or abnormal.

    A gas exchange defect will be indicated by a reduced maximum oxygen consumption, inefficient ventilation and, in more severe cases, a significant decrease in SaO2. These findings are not specific to obstructive (COPD, not asthma) or restrictive diseases. Even patients with normal lung mechanics can have limitations in gas exchange, a prime example of this being a pulmonary emboli. Elevations in Ve/VCO2 and Ve-VCO2 slope are also frequently seen in cardiac disease

    It should also be apparent that it is necessary to review all of the raw test data, not just that presented for baseline, AT and peak
    exercise. Summary reports automatically generated by test systems often have inaccuracies in how test data is selected and averaged and these reported results should always be verified.

    As always however, attention should be paid to test quality as suboptimal testing can skew results.

    Next: CPET Interpretation part 3: Cardiovascular response to exercise

    Previous:
    CPET
    interpretation part 1: Ventilatory response to exercise

    Appendix:
    Wasserman’s VO2 calculation algorithm

    Male:

    Cycle factor = 50.72 – (3.72 x
    age)

    Predicted
    weight (kg) = (0.79
    x height (cm)) – 60.7

    If actual weight = predicted
    weight then:

    VO2 (ml/min) = Actual weight x cycle factor

    If actual weight < predicted
    weight then:

    VO2 (ml/min) = ((Predicted weight + actual weight) / 2) x cycle factor

    If actual weight > predicted
    weight then:

    VO2 (ml/min) = (predicted weight x cycle factor) + (6 x (actual weight – predicted weight))

    If treadmill is used rather than
    a bicycle ergometer then multiply VO2 by 1.11

    Female:

    Cycle factor: 22.78 x (0.17 x
    age)

    Predicted weight (kg) = (0.65 x
    height (cm)) – 42.8

    If actual weight = predicted
    weight then:

    VO2 (ml/min) = (actual weight (kg) + 43) x cycle factor

    If actual weight < predicted
    weight then:

    VO2 (ml/min) = ((predicted weight + actual weight + 86) / 2) x cycle factor

    If actual weight > predicted
    weight then:

    VO2 (ml/min) = ((predicted weight + 43) x cycle factor) + (6 x (actual weight – predicted weight))

    If treadmill is used rather than
    a bicycle ergometer then multiply VO2 by 1.11

    Note:
    Wasserman et al does not
    specify over what range an actual weight should be considered the
    same as the predicted weight (particularly since they are very rarely
    if ever
    identical). As a rule of thumb I use +/- 10% as an acceptable
    “normal” range.

    References:

    Balady
    GJ; et al. Clinician’s guide to cardiopulmonary exercise testing in
    adults: A scientific statement from the American Heart Association.
    Circulation 2010; 122: 191-225.

    Wasserman K, Hansen JE, Sue DY,
    Stringer WW, Whipp BJ. Principles of exercise testing and
    interpretation, 4th edition, page 166. Lippincott,
    Williams and Wilkins, publisher.

    PFT
    Blog by Richard
    Johnston

    is
    licensed under a Creative
    Commons Attribution-NonCommercial 4.0 International License
    .

  • CPET Test Interpretation, Part 1: Ventilatory response

    I’ve
    always found interpreting CPET tests to be one of the more
    interesting (and enjoyable) things I’ve done. Interpreting a CPET
    test is both more difficult and easier than interpreting regular
    PFTs. More difficult because there are a lot more parameters
    involved and easier because determining test adequacy and the primary
    cause(s) of an exercise limitation tends to be clearer.

    I’ve
    found that you have to go back to basic physiology whenever you
    interpret CPETs and that always boils down to the flow of oxygen and
    carbon dioxide.

    Abnormalities
    in gas flow that occurs at any of these steps will leave a
    distinctive pattern in the test results. I’ve developed a
    structured approach to interpreting CPET results that includes a
    descriptive part as well as the interpretation and summary. The
    descriptive part may appear to be tedious but I’ve always found it
    to be absolutely critical to the actual interpretation.

    The
    descriptive elements for assessing the ventilatory response to
    exercise are:

    What was the baseline spirometry?

    Note: Spirometry pre- and post-exercise should always be performed as part of a CPET, even when exercise-induced bronchoconstriction is not suspected. This is so that normal values for the ventilatory response to exercise can be determined.

    Example: The FVC was {normal | mildly reduced | moderately reduced | moderately severely reduced | very severely reduced}. The FEV1 was {normal | mildly reduced | moderately reduced | moderately severely reduced | very severely reduced}. The FEV1/FVC ratio was was {normal | mildly reduced | moderately reduced | severely reduced}.

    What was the post-exercise change in FEV1?

    A decrease in FEV1 ≧
    15% following exercise is abnormal and suggests exercise-induced
    bronchoconstriction.

    Note: FEV1 can increase post-exercise and an increase up to 5% is normal. Some patients with reactive airway disease bronchodilate with exercise and can an increase ≧ 15% from baseline, particularly if they were obstructed to begin with. Although strictly speaking this is not abnormal, it does suggest the presence of labile airways.

    Example: There was {a significant decrease / no significant change / a significant increase} in FEV1 following exercise.

    What was the maximum minute ventilation (Ve) in percent predicted?

    Predicted Ve is calculated from
    (FEV1 x 40).

    Note: MVV tests are generally not useful in determining maximum exercise ventilation because they are of short duration and as importantly, they are an artificial maneuver that many patients have difficulty performing correctly and does not correlate well with the type of ventilation that occurs with exercise.

    A
    normal maximum minute
    ventilation is usually
    less than 60% of
    predicted.

    If the maximum minute
    ventilation is ≧
    85% of predicted then a pulmonary mechanical limitation is present
    and may be due to a:

    1. Restrictive process

    2. Obstructive process

    3. Hyperventilation

    Note: A maximum minute ventilation > 100% of predicted suggests suboptimal baseline spirometry but occasionally occurs in patients with very severe airway obstruction.

    Historical Note: The Dyspnea Index (DI, often found in older publications) is ((maximum Ve/predicted maximum minute ventilation) x 100), i.e. percent predicted.

    Example: The maximum minute ventilation was XX.X LPM which is X% of predicted and is {within normal limits | elevated}.

    What was the minute ventilation at Anaerobic threshold (AT)?

    If the CPET test is submaximal a
    minute ventilation > 45% of predicted at AT is an indication that
    there is likely a pulmonary mechanical limitation.

    Example: The minute ventilation at AT was {within normal limits | elevated}.

    What was the resting and maximum tidal volume (Vt)?

    A
    resting Vt is nominally 0.5 to 1.0 L. Vt normally increases by a
    factor of 2 to 3 from rest to peak exercise. When ventilation
    increases during exercise tidal volume usually increases first,
    followed by respiratory rate. A blunted increase in tidal volume (<
    2x resting) can be seen in both restrictive and obstructive disease

    Note: Some patients breathe slowly and deeply during the baseline period and this will skew the apparent Vt response downwards.

    Example: There was a {blunted | normal} increase in tidal volume during exercise.

    What was the resting and maximum respiratory rate (RR)?

    A resting RR is nominally 10 to 20 breaths per minute and normally increases to between 30 and 40 breaths per minute during exercise.

    A
    resting RR > 25 is abnormal and suggests hyperventilation but is
    also often seen in pre-test anxiety.

    A
    RR > 55 at peak exercise is abnormal and is most often seen with
    restrictive diseases.

    A
    blunted increase in RR (<30 at peak exercise) is often seen in
    obstructive diseases.

    Example: There was a {blunted | normal | elevated} increase in respiratory rate during exercise.

    What was the E/I ratio at peak exercise?

    Note: I prefer to use E/I (expiratory time/inspiratory time) rather than the I:E ratio because it is clearer when you say it is increased or decreased and because it focuses attention on the expiratory part of ventilation.

    E/I
    ratio is nominally 1.0 to 2.0 at rest and should approach 1.0 at peak
    exercise in normal subjects.

    An
    E/I ratio > 1.5 at peak exercise is usually seen when airway
    obstruction is present.

    An
    inverse E/I ratio (<1.0) at peak exercise is an indication there
    may be an inspiratory obstruction.

    Example: The E/I ratio was {inverse | normal | elevated} at peak exercise.

    What was the Vt/IC ratio at peak exercise?

    Note: If it is possible to measure Inspiratory Capacity (IC) then this should be done during the resting baseline period and regularly during exercise. This allows the Vt/IC ratio and changes in the End-Expiratory Lung Volume (EELV) to me calculated. Both the Vt/IC ratio and EELV are critical towards measuring the ventilatory response in patients with airway obstruction.

    Note: The Vt/IC ratio can be overestimated from suboptimal IC maneuvers and the maneuver can be difficult to perform at higher levels of exercise. By definition it can never be higher than 1.0.

    Note: Always confirm test system measurements of IC and EELV since these machine-generated measurements are often inaccurate due to difficulty in assessing the start of the IC maneuver.

    A
    Vt/IC ratio greater than 0.85 at peak exercise is abnormal and can be
    seen in both obstructive and restrictive diseases.

    Note: A Vt/IC ratio > 0.85 may also be an indication the patient has reached a pulmonary mechanical limitation to exercise even when the maximum minute ventilation was <85% of predicted.

    Example: The Vt/IC ratio at peak exercise was {within normal limits | elevated}.

    What was the change in EELV at peak exercise?

    EELV
    is calculated from (baseline IC – exercise IC). No change or a
    decrease is normal. An increase in EELV ≧0.25
    L. suggests gas trapping (dynamic hyperinflation) and is usually seen
    in obstructive disease.

    Note: Dynamic hyperinflation can cause the patient to reach a pulmonary mechanical limitation even though the maximum minute ventilation was <85% of predicted.

    Example: EELV at peak exercise {decreased by X.X L. | did not change significantly | increased by X.X L) which is {within normal limits | elevated}.

    After having gone through this checklist it should be apparent whether the ventilatory response to exercise was normal or abnormal, and as importantly, specifically which element was normal or abnormal.

    There
    are distinctive patterns in the ventilatory response for obstructive
    and restrictive lung diseases. Even when if a preliminary diagnosis
    of this kind is not known prior to testing baseline spirometry should
    at least suggest the presence (or absence) of one or the other.

    Depending
    on the severity of their disease, patients with obstructive lung
    disease will have:

    • a
      reduced FEV1 and FEV1/FVC
      ratio
    • an elevated maximum minute ventilation
    • an elevated minute volume at AT
    • a blunted increase in tidal volume
    • a blunted increase in respiratory rate
    • an elevated E/I ratio
    • an elevated Vt/IC ratio
    • an elevated increase in EELV

    Depending
    on the severity of their disease, patients with restrictive lung
    disease will have:

    • a
      reduced FVC and a normal or elevated FEV1/FVC ratio.
    • an
      elevated maximum minute volume
    • an
      elevated minute volume at AT
    • a
      blunted increase in tidal volume
    • an
      elevated increase in respiratory rate
    • a
      normal E/I ratio
    • an
      elevated Vt/IC ratio
    • a
      normal increase in EELV

    It
    should be pointed out that even patients with normal lung mechanics
    can reach a pulmonary mechanical limitation, either because gas
    exchange abnormalities cause them to have an exaggerated ventilatory
    response or by being incredibly fit with an markedly elevated maximum
    oxygen consumption.

    As
    always however, attention should be paid to test quality as
    suboptimal spirometry, inspiratory capacity and exercise testing can
    skew results.

    Next: CPET Test Interpretation, part 2: Gas exchange

    Creative Commons License

    PFT Blog by Richard Johnston is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

  • Sharing opinions with Paul Enright

    Dr. Paul Enright is a well-known name in the field of Pulmonary Function testing. He is the lead author or co-author of over a hundred articles and has served on many of the ATS/ERS standards committees.

    Introduction:

    We
    both retired in southern Arizona and live
    a couple of towns apart from each other. We have corresponded for a
    while but met
    face-to-face
    only
    recently.
    We both drive small red vehicles, Richard a Ford
    Transit Van and Paul a Prius Compact. We both love to visit
    National Parks; Richard’s favorite is Canyonlands
    while Paul’s favorite is Jasper, with many large wild animals. This
    posting is based on a set of suggestions by Paul.

    In
    which hospital-based PFT labs have you worked?

    Richard:
    St. Elizabeth’s then Beth
    Israel Deaconess Medical Center, both
    in Boston.

    Paul:
    I started a very small PFT lab at the Kuakini Hospital in Honolulu;
    then the basement lab of the National Jewish Hospital in Denver,
    Colorado; then the Plummer Building of the Mayo Clinic in Rochester
    Minnesota; then the University Medical Center in Tucson, Arizona;
    then a NIOSH van running out of Morgantown, West Virginia.

    Which
    is the largest PFT lab that you ever visited?

    Richard:
    the
    PFT Lab at Mass General in Boston.

    Paul:
    INER in Mexico City, where they test more than 10,000 patients per
    year. The medical director of the lab is my friend Laura G. One
    year a guard with a shotgun stood outside the lab because the payroll
    with bonuses for the institution was stolen the previous month
    (December).

    Which
    PFT number should be removed from PFT reports?

    Richard:
    FEF25-75
    (aka MMEF) because
    it’s usually only abnormal when the FEV1 is abnormal (and
    because it has nothing to do with small airways).

    Paul:
    DL/VA,
    because it is often normal in patients with interstitial lung
    disease.

    Which
    PFT should be added to labs?

    Richard:
    Possibly
    the Lung
    Clearance Index (LCI). Results
    are well characterized in a pediatric population and it may add
    something to the clinical monitoring of COPD.

    Paul:
    Allergen skin prick tests. There are only six allergens which cause
    inflammation of airways in the lungs, thereby causing asthma
    exacerbations: cat, dog, mold, cockroach. and two types of house dust
    mites. Patients with asthma who are positive to one or more of these
    allergens can reduce the concentrations of these allergens in their
    home, thereby reducing their need for asthma medications.

    Which
    are the three most important PFT numbers?

    Richard:
    FEV1/FVC
    ratio, FEV1 and DLCO.

    Paul:
    FEV1, FVC, and DLCO.

    Which
    is the most expensive PFT instrument that most labs could do without?

    Richard:
    Plethysmograph.
    Lung
    volume tests rarely add anything to the clinical picture.

    Paul:
    Once you have spirometry, DLCO, and a chest x-ray results, body box
    tests (lung volumes and airway resistance) add no clinically useful
    information.

    Which
    PFT is done with the worst accuracy?

    Richard:
    Airway
    resistance (RAW and Sgaw).

    Paul:
    Forced inspiratory flows which follow FVC maneuvers (aka flow-volume
    loops) are usually submaximal efforts. The false positive rate for
    upper airway obstruction is large, so most doctors just ignore the
    results.

    What
    was the first spirometer you ever used?

    Richard:
    Collins
    Modular Lung Analyzer equipped with Gaensler’s automated SB DLCO.
    The
    stainless steel spirometer bell was counterweighted with a chain and
    the kymograph pen was attached to the counterweight.

    Paul:
    The McKesson Vitalor. It had a small rubber bellows which was rarely
    cleaned, so it probably transmitted tuberculosis from one patient to
    the next.

    Which
    previously popular PFT was abandoned during your career?

    Richard:
    Closing
    Volume. Popular for a while and thought to provide an early
    diagnosis for smoking-caused airway obstruction which
    has since proven not to be the case.

    Paul:
    The maximal voluntary ventilation (MVV or MBC) test. It caused
    patients to hyperventilate, get dizzy, and fall off the chair.

    What
    do you think of the forced oscillation tests?

    Richard:
    Difficult
    to understand with inadequate
    clinical correlation.

    Paul:
    After 65 years, they are still not ready for prime time (except
    perhaps for pre-school children with asthma symptoms who simply
    cannot perform FVC maneuvers).

    What
    is the best PFT book for technologists?

    Richard:
    Manual
    of Pulmonary Function Testing, originally edited by Greg Ruppel, now
    by Carl Mottram.

    Paul:
    Lung
    Function Tests. Physiological Principals and Clinical Applications.
    Edited by JMB Hughes and NB Pride.

    What’s
    wrong with the six minute walk test?

    Richard:
    Finding
    a traffic-free corridor that’s long enough.

    Paul:
    Many locations don’t have a 30 meter long corridor or hallway. Most
    pulse oximeters give falsely low SpO2s during
    the walk, due to motion artifact.

    What
    is the most promising new PFT?

    Richard:
    Although
    not a new test, possibly the LCI.

    Paul:
    I don’t know any.

    Who
    was your favorite PFT mentor?

    Richard:
    Steve
    Weinberger.

    Paul:
    Joe Rodarte (RIP) who always wore cowboy boots to work in Minnesota,
    was transfixed by young women, but moved to Houston, Texas.

    What
    is your favorite spirometer?

    Richard:
    Vitalograph
    Pneumotrac.

    Paul:
    I have purchased hundreds of ndd EasyOnes for research studies.

    What
    do you like about the new 2019 spirometry standards (guidelines)?

    Richard:
    The
    distinction is finally
    made
    between test quality and test useability.

    Paul:
    Quality grades for both FEV1 and FVC. These provide the doctor who
    ordered the test an indication of the degree of confidence that she
    should place in the numerical results.

    Big
    Pharma buys more spirometers than anyone.

    Why?

    Richard:
    Presumably
    for clinical trials although almost always low-end spirometers with
    limited accuracy.

    Paul:
    Their only goal is to sell more COPD inhalers, which have been
    proven not to prolong life or reduce rapid decline in lung function
    caused by smoking.

    Is
    it okay to stop FVC maneuvers after six seconds?

    Richard:
    No.
    An FVC maneuver should go until no more air is coming out,
    regardless of whether this is less than or greater than 6 seconds.
    There
    is nothing magic about 6 seconds.

    Paul:
    Only if they have reached a volume-time plateau or you are comparing
    the results with reference equations for the FEV1/FEV6.

    What
    is the most clever device you have seen in a PFT lab?

    Richard:
    Nothing
    comes to mind…

    Paul:
    a target on the wall across from the patient. During FVC maneuvers,
    they are instructed to look at the target. This keeps their chin up.
    They can also be told to pretend that they are using a blow tube
    with a dart inside. This encourages a high peak flow.

    What
    is the best way to minimize the risk of cross-contamination in a PFT
    lab?

    Richard:
    Disposable
    mouthpieces and noseclips.

    Paul:
    Wash your hands before and after testing each patient. Have plenty
    of space between the chairs in the waiting area.

    What
    was the largest FVC you ever saw?

    Richard:
    8.6
    liters in a 7 foot 2 inch tall male.

    Paul:
    Ten liters. But in retrospect it was because the flow sensor had
    been clogged with phlegm.

    Is
    it okay to only obtain one good DLCO maneuver?

    Richard:
    No,
    although
    most of the time there is no significant difference they
    should be done at least twice to
    be sure.

    Paul:
    That’s all they do in several large PFT labs. I once wanted to prove
    that this gave inaccurate results when compared to reporting the
    average of two good tests, but the results were only wrong about five
    percent of the time. Of course I didn’t publish that retrospective
    study.

    In
    your experience, where is the worst quality spiromety performed?

    Richard:
    Office
    spirometry with poorly trained staff.

    Paul:
    By techs testing people previously exposed to asbestos in their
    workplace.

    Who
    was your favorite PFT equipment salesperson?

    Richard;
    Tom
    Carpenter, originally from Collins, then
    Ferraris and finally Nspire. Always
    cheerful and informative.

    Paul:
    Jeurg Adenauer. We traveled to many countries together, using the
    EasyOnePro during workshops at annual meetings. The professional
    societies laundered the money for my travel. My last such meeting
    was in Bogota, Columbia.

    What
    do you consider your biggest career success?

    Richard:
    The
    PFT Blog.

    Paul:
    Pulling Philip Quanjer (RIP) out of retirement to fight the faulty
    fixed ratio advertised by the GOLD guidelines. He then assembled an
    international group who developed the GLI equations.

    Should
    primary care practitioners be encouraged to perform spirometry in
    their outpatient offices?

    Richard:
    Office
    spirometry test quality is often poor but at least the physician is
    attempting to get an answer and questionable patients are usually
    referred to a hospital-based PFT Lab.

    Paul: I wrote a book in 1987 called Office Spirometry. However, I now think that they should be able to order a spirometry test just like a CBC or chest x-ray, done quickly at a convenient location by certified technologists who are only paid for good quality tests (grade A or B). For example, vampires who work for Quest or LabCorp in the Untied States could have their quality verified centrally. First read the book “Bad Blood.”

    Creative Commons License

    PFT Blog by Richard Johnston is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

  • N2 washout is affected by N2 excretion and other factors

    The Lung Clearance Index (LCI) was first described in 1952 by Margaret Becklake, and is defined as the number of lung volume turnovers required to reduce the concentration of a tracer gas by a factor of 40. LCI is calculated as the cumulative exhaled volume (CEV) during the washout divided by the functional residual capacity (FRC).

    Clinically
    LCI has been used most often in individuals with cystic fibrosis and
    this is because the LCI has been repeatably shown to be sensitive to
    changes in airway status that are not reflected in the FEV1. LCI has
    shown similar results in patients with primary ciliary dyskinesia.
    As expected LCI has also been tested on patients with COPD,
    bronchiectasis and asthma although these patients tend to show a
    better correlation between FEV1 and LCI.

    LCI
    has been performed using a wide variety of tracer gases including
    helium, methane, argon, nitrogen and sulfur hexaflouride (SF6). The
    commercial systems that are currently available use either N2 or SF6.
    N2 washout LCI has recently received a great deal of criticism and
    some of these criticisms seem to apply to N2 washout lung volumes as
    well.

    Most
    specifically, a number of studies have noted that the N2 washout FRC
    is routinely higher than the SF6 FRC and plethysmographic FRC. In
    addition, the N2 washout LCI tends to be significantly higher than
    the SF6 LCI and this difference increases as LCI increases.

    As
    examples in a study of patients with COPD the N2 washout FRC averaged
    14% higher than the plethysmographic FRC. In other studies of normal
    subjects the N2 washout FRC was on average 0.20 to 0.21 L higher than
    plethysmographic FRC. Finally, a study that performed N2 and SF6
    washouts simultaneously on CF patients and healthy controls showed
    the N2 washout LCI to be on average 7.93% higher than SF6 in the
    healthy controls and 29.13% higher than SF6 in the CF patients. In
    the same study N2 washout FRC was 12.66% higher than SF6 FRC in the
    healthy controls and 30.09% higher than SF6 FRC in CF patients.

    So
    why is there such a discrepancy?

    One
    of the primary reasons appears to be N2 excretion from N2 body stores
    during the 100% O2 washout. Nitrogen excretion is complex because
    nitrogen comes from a variety of body stores with different time
    constants. Depending on the time interval during a 100% O2 washout,
    nitrogen will be excreted from blood first, well perfused tissue
    second, poorly perfused tissue third and fat last. N2 excretion has
    been studied several times since the 1930’s and although results
    are in general similar, the derived formulas differ. In addition,
    the excretion rates of individuals have been shown to differ due to
    differences in body mass and in ventilation, and likely for
    differences in cardiac output, ventilation inhomogeneity and dead
    space as well.

    N2 excretion slope. Note that N2 excretion scale is semi-logarithmic. Modified from Beatty PCW, Kay B, Healy TEJ. Measurement of the rates of nitrous oxide uptake and nitrogen excretion in man. Br J Anaesth 1984; 56: Figure 2, page 225.

    The
    extent to which the N2 washout FRC differs from plethysmographic FRC
    and SF6 washout FRC tends to increases as test time increases. This
    makes sense in that during longer tests individuals spend a
    proportionally longer time at lower alveolar N2 concentrations which
    enhances N2 excretion and increases the relative contribution it
    makes to exhaled N2. Interestingly, during the latter part of the
    washout the best ventilated parts of the lung will contain the
    highest concentrations of oxygen and have the highest N2 gradient. N2
    excretion will therefore be highest in these parts of the lung.

    There
    have been several attempts to correct for N2 excretion using both
    fudge factors and more precise formulaic corrections with varying
    degrees of success. One study using the formula from Lundin and
    Cournand showed a partial but not complete decrease in the difference
    between N2 washout FRC and plethysmographic FRC, and the improvement
    was greater for normal subjects than it was for those with CF.
    Another study that used a fudge factor (subtracting 1% from the N2
    concentration throughout testing) however, showed FRC and LCI results
    significantly more similar to to those of SF6 studies.

    So N2 excretion is a major factor, but it may not be the sole factor.

    The way in which N2 is analyzed has been suggested as another reason for the discrepancy. Specifically in all commercial test systems, N2 is not measured directly, it is instead derived from oxygen and carbon dioxide concentrations. One study showed that the derived N2 signal was reasonably accurate across the entire range of expected concentrations with all measured differences being within 0.12%. Another study however, found that when they presented the analyzers with a zero percent N2 mixture the instrument read between 0.62% and 1.06% N2 (average 0.8%) and that correcting (as well as correcting for N2 excretion) significantly decreased the difference between N2 washout and SF6 washout FRC measurements. Finally, in a letter to the editor the author suggested that an error of 0.2% in O2 concentration, which is within normal limits for most oxygen analyzers, could lead to an error of over 2% in the indirect N2 concentration.

    Note: When the N2 concentration is estimated using measured O2 and CO2 concentrations one factor that I’ve not seen explicitly addressed is the argon concentration. Argon makes up approximately 0.9% of air and although it will be washed out along with N2 during an 100% O2 washout it contributes to the resting baseline. In particular, the room air concentration of N2 + AR is 79.01% but most test system presume the starting concentration of N2 used in their calculations to be 78.08%.

    Another
    factor that’s been raised by several researchers is the cutoff N2
    concentration. LCI washouts, regardless of which gas is being used,
    nominally stop when the tracer gas is 1/40th the starting
    concentration, which is usually considered to be 2% or 2.5%. Several
    researchers have shown that a higher cutoff such as 5% shortens the
    washout and decreases the differences between SF6 and N2 washout FRC
    and LCI. Test sensitivity is reduced with a 5% cutoff but several
    studies showed that clinical and statistical significance did not
    change significantly.

    It
    has been repeatedly shown that N2 washout LCI tests produce higher
    FRC and LCI measurements than testing with SF6. N2 washout tests
    also tend to be longer than SF6 tests and it has been suggested that
    a higher cutoff value for N2 would be appropriate. N2 excretion
    during the 100% O2 washout is likely the primary factor in the
    discrepancy between N2 and SF6 FRC and LCI results but N2 excretion
    is complex and not necessarily predictable. Although correcting for
    N2 excretion reduces the discrepancy it does not eliminate it and it
    has been suggested that minor offset errors in the gas analyzers may
    also contribute to the discrepancy.

    When
    appropriate care is taken however, N2 washout values are repeatable
    and although the magnitude of the results may be exaggerated compared
    to SF6 their direction and sensitivity remains relevant. This does
    mean however, that the normal values for LCI testing will depend on
    which gas is being used.

    A
    final note is that although the 2005 ATS/ERS guidelines for N2
    washout lung volumes acknowledges N2 excretion the suggested
    correction factor:

    N2 tissue excretion (mL) = ((BSA x 96.5)+35)/0.8

    does
    not correct for test time and should be considered to be more of a
    fudge factor than an accurate correction.

    References:

    Beatty
    PCW, Kay B, Healy TEJ. Measurement of the rates of nitrous oxide
    uptake and nitrogen excretion in man. Br J Anaesth 1984; 56:
    223-232.

    Becklake
    MR. A new index of the intrapulmonary mixture of inspired air. Thorax
    1952; 7: 111-116.

    Bell
    AS, Lawrence PJ, Singh D, Horsley A. Feasibility and challenges of
    using multiple breath washout in COPD. Int J COPD 2018; 13:
    2113-2119.

    Benseler
    A, Stanojevic S, Jensen R, Gustaffson P, Ratjen F. The effect of
    equipment dead space on multiple breath washout measures.
    Respirology 2015; 20(3): 459-466.

    Brusasco
    V, Crapo R, Viegi G, et al. Series ATS/ERS task force:
    Standardisation of lung function testing. Standardisation of the
    measurement of lung volumes. Eur Respir J 2005; 26: 511-522.

    Cournand
    A YI, Riley RL. Influence of body size on gaseous nitrogen
    elimination during high oxy-gen breathing. Proc Soc Exp Biol Med
    1941; 48: 280–284.

    Jensen
    R, Stanojevic S, Gibney K, Salazar JG, Gustafsson P, et al. (2013)
    Multiple Breath Nitrogen Washout: A Feasible Alternative to Mass
    Spectrometry. PLoS ONE 8(2): e56868

    Kane
    M, Stanojevic S, Jensen R, Ratjen F. Effect of tissue nitrogen
    excretion on multiple breath washout measurements. Eur Respir J
    2016; 48: PA370.

    Kane
    M, Rayment JH, Jensen R, McDonald R; Stanojevic S, Ratjen F.
    Correcting tissue nitrogen excretion in multiple breath washout
    measurements. PLOS One 2017;
    12(10): e0185553.

    Lokesh
    G, Kasi A, Starks
    M, Pedersen
    KE, Nielsen JG, Weiner DJ. Difference
    between SF6 and N2 multiple breath washout kinetics is due to N2 back
    diffusion and error in N2 offset,
    J
    Appl Physiol, 2019; 125(4), 1257-1265.

    Lundin
    G.
    Nitrogen elimination during oxygen breathing. Acta Physiol Scand
    1953;
    30:
    130–143.

    Nielsen
    JG. Lung clearance index: should we really go back to nitrogen
    washout (letter to editor). Eur Repir J; 43: 655-656.

    Nielsen
    N, Nielsen JG, Horsley AR. Evaluation of the impact of alveolar
    nitrogen excretion on indices derived from multiple breath N2
    washout. PLOS One 2013; 8(9); e73335.

    Robinson
    PD, Latzin P, Gustafsson PM. Multiple-breath washout. Eur Repir Mon;
    47: 87-104.

    Nyilas
    S, Schlegtendal A, Singer F, et al. Alternative inert gas washout
    outcomes in patients with primary ciliary dyskinesia. Eur Respir J
    2017; 49: 1600466

    Tonga
    KO, Robinson PD, Farah CS, King GG, Thamrin C. In vitro and in vivo
    comparisons between multiple-breath nitrogen washout devices. ERJ
    Open Research 2017; 3: 00011-2017.

    Yammine S, Lenherr N, Nyilas S, Singer F, Latzin P. Using the same cutoff for sulfur hexaflouride and nitrogen multiple-breath washout may not be appropriate. J Appl Physiol 2015; 119: 1510-1512.

    Creative Commons License

    PFT Blog by Richard Johnston is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

  • FEV1 and VC should be measured separately

    The
    FEV1 and VC both provide quite different information about a
    patient’s lungs. Unfortunately, spirometry as it is currently
    practiced is optimized towards generating an accurate FEV1 more than
    an accurate VC. This is partly due to limitations in the maneuver
    itself and partly due to the lack of accurate end-of-test criteria
    for an adequate VC. In one sense this is okay since more than one
    person that I’ve known and respected has said that “it’s all
    about the FEV1”.

    Having
    said that, an accurate FEV1/VC ratio is essential for detecting and
    quantifying airway obstruction and an SVC maneuver is more likely to
    obtain a more accurate VC. This matters because the current ATS/ERS
    spirometry guidelines recommend that the FEV1/VC be reported, where
    the VC is the largest value obtained from any test and reference
    equations indicate that the SVC is routinely larger than the FVC:

    So,
    shouldn’t we be routinely performing both FVC and SVC maneuvers
    when we do spirometry on our patients? And why aren’t we?

    Well
    first, although many test systems allow both FVC and SVC maneuvers to
    be performed relatively few of them will actually report the FEV1/VC
    ratio. The ATS 2017 reporting standards does mandate this, but here
    we are two years later and my lab has had no updates in our reporting
    software. If we want to report the FEV1/VC ratio we have to do so
    manually in the notes. This is a major hurdle that many are not
    willing to overcome.

    Second,
    many clinics and doctor’s offices struggle just to perform adequate
    spirometry, nominally according to the ATS/ERS standards. There is
    frequently an additional struggle to understand what the results mean
    and simplistic algorithms are often used to make sense of them.
    Performing and using SVC measurements in this kind of environment is
    just too confusing to be considered, particularly since there is no
    mandate to use them.

    Third,
    performing SVC as well as FVC maneuvers takes extra
    technician/patient time that just may not be considered to be
    available. I would argue that performing a shortened FVC maneuver
    optimized for FEV1 and SVC maneuvers optimized for VC will actually
    take little extra time but many (including the physicians I work
    with) would disagree.

    Fourth,
    there very few good FEV1/VC ratio reference equations. There are
    only two studies (Gutierrez, Marsh) where FVC and SVC were studied in
    the same population and where a predicted FEV1/VC ratio can be
    calculated. All other reference equations, including the NHANESIII
    and GLI reference equations, can only produce a predicted FEV1/FVC.
    Since SVC is usually larger than FVC, this means that the predicted
    FEV1/SVC ratio is smaller than the FEV1/FVC ratio and it’s remotely
    possible that the presence of airway obstruction would therefore be
    overestimated. I would argue that SVC is accurate more often than
    FVC and that the FEV1/VC is therefore more likely to accurate more
    often as well.

    Fifth
    and finally, there is no mandate to perform both FVC and SVC
    maneuvers. There is nothing in the 2005 ATS/ERS that says this
    should be done and SVC is almost always performed only when lung
    volume measurements are performed. Many if not most PFT labs hew
    closely to the ATS/ERS standards, and for good reason as this is the
    only way to be sure results are reproducible and transportable.

    So
    although there are excellent reasons why both FVC and SVC should be
    routinely performed there are many significant obstacles towards
    doing so. To be honest my lab doesn’t routinely perform both
    maneuvers (despite my urging otherwise) and this is mostly because of
    reasons one, three and five.

    Realistically
    it would take something like an updated ATS/ERS spirometry standard
    that mandated separate FVC and SVC maneuvers for this to become
    commonplace. Still, there will be select patients where getting a
    true VC and FEV1/VC ratio will be beneficial and we should be open to
    performing extra testing when it is needed.

    Note: One work-around is to use the standard spirometry test module to perform an SVC maneuver. The FEV1 from the maneuver would be ignored and many test systems will allow the FEV1 and (F)VC from separate maneuvers to be combined and reported. We use this as needed in my PFT Lab.

    Note: Very unofficially I have heard that the ATS/ERS will be releasing new spirometry standards sometime in 2019. I look forward to seeing them.

    References:

    Brusasco
    V, Crapo R, Viegi G. ATS/ERS task force: Standardisation of lung
    function testing. Standardisation of spirometry. Eur Respir J 2005;
    26(2): 318-339.

    Brusasco
    V, Crapo R, Viegi G. ATS/ERS task force: Standardisation of lung
    function testing. Interpretive strategies for lung function tests.
    Eur Respir J 2005; 26(6): 948-968.

    [A]
    Cordero PJ, Morales P, Benlloch E, Miravet L, Cebrian J. Static Lung
    Volume: Reference values from a Latin population of Spanish descent.
    Respiration 1999; 66: 242-250.

    [B]
    Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volume in healthy
    nonsmoking adults. Bull Eur Physiopathol Respir 1983; 18: 419-425

    Graham
    BL, Coates AL, Wanger J et al. Recommendations for a standardized
    pulmonary function report. An official American Thoracic Society
    technical statement. Am J Respir Crit Care Med 2017; 196(11):
    1463-1472

    [C]
    Gutierrez C, et al. Reference values of pulmonary function tests for
    Canadian caucasians. Can Respir J 2004; 6: 414-424.

    [D]
    Hankinson JL, Odencrantz JR, Fedan, KB. Spirometric reference values
    from a sample of the general U.S. Population. Amer J Resp Crit Care
    1999; 159: 179-187

    [E]
    Johannessen A, Lehmann S, Omenaas ER, Side GE, Bakke PS, Gulsvik A.
    Post-bronchodilator spirometry reference values in Adults and
    implications for disease mangement. Amer J Resp Crit Care Med 2006;
    173(12): 1316-1325

    [F]
    Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the
    normal maximal expiratory flow volume curve with growth and aging.
    Am Rev Resp Dis 1983; 127: 725-734

    [G]
    Kuster SP, Kuster D, Schindler C, Rochat MK, Braun J, Held L, Brandli
    O. Reference equations for lung function screening of healthy
    never-smoking adults aged 18-80 years. Eur Respir J 2008; 31:
    860-868.

    [H]
    Marsh S, Aldington S, Williams M, Weatherall M, Shirtcliffe P,
    McNaughton A, Pritchard A, Beaseley R. Complete reference ranges for
    pulmonary function tests from a single New Zealand population. New
    Zealand Med J 2006; 119: N1244.

    [I]
    Morris JF, Koski A, Johnson LC. Spirometric standards for healthy
    nonsmoking adults. Am Rev Resp Dis 1971; 103: 57-67.

    [J]
    Morris JF, Koski A, Temple WP, Claremont A, Thomas DR. Fifteen-year
    interval spirometric evaluation of the Oregon Predictive equations.
    Chest 1988; 93: 123-27

    [K]
    Neder JA, Andreoni S, Castelo-Filho A, Nery LE. Reference values for
    lung function tests. I. Static Volume. Braz J Med Biol Res 1999;
    32: 703-717

    [L]
    Pereira CADC, Sato T, Rodrigues SC. New Reference Values for forced
    spirometry in white adults in Brazil. J Bras Pneumol 2007; 33:
    397-406.

    [M]
    Roberts CM, MacRae KD, Winning AJ, Adams L, Seed WA. Reference
    values and prediction equations for normal lung function in a
    non-smoking white urban population. Thorax 1991; 46: 643-650.

    [N] Stocks J, Quanjer PH. Reference values for residual volume, function residual capacity and total lung capacity. Eur Respir J 1995; 8: 492-506.

    Creative Commons License

    PFT Blog by Richard Johnston is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

  • I’M BACK, SORT-OF

    The chemo did a real number on me. I was included in a study of a new drug and it literally almost killed me. Twice. For this reason I have left the study and have been put on a gentler and more normal regime of chemo. I have lost a lot of stamina (and strength and weight) but have recovered somewhat. I have returned to catch up on comments as best I can and apologize for not responding for so long.

    If possible I will post something new but it will probably be a while before I feel up to doing so.

    Thanks to everybody for their kind and supportive thoughts.

  • Goodbye

    This is probably the last post I will be able to write.  I was diagnosed less than two months ago with a very nasty cancer with a poor prognosis.  I thought I could power through it but a serious infection with sepsis and a week and a half stay in the hospital has convinced me that it’s time to quit and focus on other things.

    Sucks, but that’s life.

    There are many pulmonary function topics I would have liked to discuss but time has run out.  I will leave you to ponder the two biggest elephants in the room; that of height and that of ethnicity.  The relationship between height and FVC, TLC, etc. is inexact and yet nobody seems to think about any alternate anthropomorphic measurements.  Sitting height is only marginally better but it is better.  Is anybody using it?  No.  C’mon people, it’s way past time that we found better anthropomorphic correlations for FVC, FEV1, TLC and DLCO.

    And what the heck is ethnicity?  Where is there a definition for it?  Although I applaud the GLI efforts for more universal FVC reference values they included fudge factors for ethnicity.  Fudge factors!!??.  It’s time that the concept of ethnicity was dropped and better (see above) anthropomorphic correlations were made.

    Keep learning.  Keep questioning.

    Goodbye.

    – UPDATE – 

    I have funded the PFTBlog, PFTHistory, PFTGuide and PFTPatient websites for the next 2 years so they will stay up for at least that long regardless of what happens to me.

    I am humbled by the responses I have received to this posting.  Thanks to all of you.